Trial reportJAMA dermatology2025
Objective Assessment of Target Vitiligo Areas by Semiautomatic Analysis of Standardized UV Images.
Trial report in JAMA dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of Vitiligo.Dermatology and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: The Target Vitiligo Area Scoring Index (Target-VASI) is the primary tool for evaluating localized vitiligo lesions; however, its uncalibrated estimation in clinical practice is limited by intrarater and interrater variability. While objective methods using tracing papers or imaging systems are available, these approaches are often tedious and rely on images that are not well contrasted. Objective: To assess the reliability and the performance of a semiautomatic analysis of the lesions performed on standardized UV reflectance pictures. Design, Setting, and Participants: This validation study was part of a prospective, double-blind, randomized, placebo-controlled clinical trial conducted between September 2023 and February 2024 at a tertiary care center to evaluate a grafting-based therapy in difficult-to-treat vitiligo lesions. Participants included adult patients with a pair of stable vitiligo target lesions with surface areas between 2 cm2 and 20 cm2. Target-VASI was measured prior to treatment and 12 weeks after treatment by using 3 methods: the image-based system (UV image Target-VASI), tracing paper outlines (tracing paper Target-VASI), and assessments by an experienced clinician (clinician Target-VASI). The image-based system involved semiautomatic analysis of standardized UV reflectance images. Main Outcomes and Measures: The Target-VASI estimation methods were compared for correlation, agreement, and repeatability, with relationships scored as weak, moderate, good/strong, and very good/very strong based on results. Results: A total of 20 adult patients with a pair of stable vitiligo target lesions of surface area between 2 cm2 and 20 cm2 were enrolled. One was lost to follow-up, resulting in 19 evaluable participants included for the analysis. The mean (SD) age was 51.7 (10.7) years, and 12 (63.8%) were female. The mean (SD) vitiligo duration was 21.2 (14.4) years. A total of 61 tracing paper Target-VASIs and 76 UV image and clinician Target-VASIs were available for analysis. UV image Target-VASIs demonstrated strong correlations with tracing paper (r = 0.81 [95% CI, 0.71-0.89]; P < .001) and clinician (r = 0.89 [95% CI, 0.83-0.93]; P < .001) Target-VASIs. The agreement was also good, with mean (SD) biases of 0.81 (0.99) and 0.52 (0.76) for tracing paper and clinician Target-VASIs, respectively. Additionally, an intraclass correlation coefficient of 0.79 (95% CI, 0.60-0.88) indicated moderate to good reproducibility of Target-VASI measurements. Although errors, such as nonmatching lesion regions and oversegmented pigmentation, were identified, the overall UV image Target-VASI accuracy was largely maintained due to the precise detection of depigmented areas. Conclusions and Relevance: In this investigation, the image-based system demonstrated reliable performance, suggesting its possible use in studies or routine clinical practice as a more efficient alternative to conventional approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.